Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Myasthenia Gravis × Sugars × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 13 cyclopia sequence 7 Prostatic Neoplasms 6 Neoplasms 6 Polycystic Ovary Syndrome 4 Lung Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Pain 3 Neoplasm Metastasis 3 Head and Neck Neoplasms 3 Fatigue 3 Vomiting 2 Urinary Bladder Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Obesity 2 Neoplasms, Plasma Cell 2 Nausea 2 Multiple Myeloma 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Insulin Resistance 2 Infertility 2 Depression 2 Burkitt Lymphoma 2 Weight Loss 1 Vitamin D Deficiency 1 Tobacco Use Cessation 1 Testicular Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1

Interventions

Rituximab 6 Pyridostigmine Bromide 5 Prednisone 5 Hizentra 4 telitacicept 3 efgartigimod alfa 3 thymoglobulin 2 Thymectomy 2 Steroids 2 Immunoglobulins, Intravenous 2 Data Collection 2 Cyclophosphamide 2 Blood Specimen Collection 2 Azathioprine 2 zilucoplan 1 tofacitinib 1 tocilizumab 1 sargramostim 1 prednylidene 1 gamma-Globulins 1 fludarabine 1 deltacortene 1 carmustine, poliferprosan 20 drug combination 1 bu-zhong-yi-qi-tang 1 apraclonidine 1 Walk Test 1 Tacrolimus 1 Tablets 1 Sugars 1 Sugammadex 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00995722 2017-06-02

EPITOME'

University of Miami

Phase 3 Terminated

11 enrolled 14 charts

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡